Published on

Toxicology: Vitamin A and Retinoids

BASICS

DESCRIPTION

Vitamin A is a fat-soluble nutrient needed for vision, immune function, and normal growth and development. It is widely available through foods and dietary supplements. Excessive exposure to preformed vitamin A or certain retinoid medications can produce significant toxicity.

FORMS AND USES

Relevant substances include vitamin A preparations and prescription retinoids such as isotretinoin, acitretin, etretinate, and tretinoin. Product names have varied by country and over time; examples in the historical source include Aquasol A, Accutane, Tegison, and Retin-A.

Oral isotretinoin is prescribed for severe acne that has not responded adequately to other treatment. Acitretin and the older retinoid etretinate have been used for severe psoriasis and other conditions involving abnormal skin keratinization.

Tretinoin is available in topical formulations for acne and certain signs of sun-related skin damage. Oral all-trans retinoic acid (tretinoin) is also used in the treatment of acute promyelocytic leukemia. The safety profiles of oral and topical formulations differ.

TOXIC DOSE

The amount associated with toxicity depends on age, formulation, the amount ingested, and whether exposure occurs once or repeatedly. Historical references reported acute toxicity after approximately 300,000 international units (IU) of vitamin A in children and 4 million IU in adults, with chronic toxicity associated with sustained intake above 25,000 IU per day. These are historical observations, not thresholds for deciding that a particular exposure is safe.

The original source advised pregnant patients not to exceed 8,000 IU of vitamin A daily. Pregnancy advice today distinguishes preformed vitamin A from beta-carotene and uses current dietary upper limits and individual prescribing guidance; excessive preformed vitamin A is especially concerning in pregnancy.

Beta-carotene does not ordinarily cause the classic hypervitaminosis A syndrome because its conversion to vitamin A is regulated, although high-dose beta-carotene supplementation has other recognized risks in certain populations.

A separate complication, now commonly called differentiation syndrome, can occur during treatment of acute promyelocytic leukemia with oral tretinoin. It should not be confused with ordinary vitamin A overdose.

PATHOPHYSIOLOGY

Beta-carotene can be converted by the body into vitamin A. Because vitamin A is fat-soluble, excessive quantities may accumulate, particularly during prolonged exposure, and damage the liver, nervous system, skin, and other tissues.

Retinoids affect gene expression and cellular differentiation. Their therapeutic actions can also account for important adverse effects, especially when exposure is excessive or occurs during fetal development.

EPIDEMIOLOGY

Clinically significant vitamin A poisoning is relatively uncommon. Cases may arise from excessively concentrated supplements, medication errors, prolonged use of high doses, or unusual food sources rich in preformed vitamin A.

CAUSES

Accidental ingestion, incorrect dosing, repeated overuse of supplements, and therapeutic retinoid exposure are possible causes. When ingestion occurs in a young child, the circumstances should be assessed carefully; suspected intentional exposure or harm requires appropriate safeguarding evaluation.

PREGNANCY AND LACTATION

High doses of preformed vitamin A and oral systemic retinoids can harm fetal development. Isotretinoin, acitretin, and etretinate are particularly concerning because of their established or substantial reproductive risks.

The source’s FDA pregnancy categories A, B, C, and X are obsolete and should not be relied upon for present-day prescribing. Risk assessment depends on the specific substance, dose, route, and timing of exposure. Topical tretinoin should not be assumed to carry the same exposure risk as oral tretinoin, although its use during pregnancy requires medical guidance.

Vitamin A can enter breast milk, and very high maternal intake may expose a nursing infant. Advice during breastfeeding should account for the specific product and dosage.

DIAGNOSIS

SIGNS AND SYMPTOMS

The central nervous system and liver are important targets of vitamin A toxicity. Symptoms may follow a large acute ingestion or develop gradually during sustained excessive intake.

Eye and head symptoms: Double vision and optic disc swelling (papilledema) may occur, sometimes associated with raised intracranial pressure.

Skin symptoms: Dryness, itching, seborrheic changes, and widespread peeling or scaling can develop.

Liver effects: Elevated liver enzymes, jaundice, and, with prolonged injury, hepatic fibrosis are possible.

Blood and coagulation: Impaired clotting may occur in patients with significant liver dysfunction.

Fluid and mineral disturbances: Elevated blood calcium concentrations (hypercalcemia) have been reported.

Neurological and general symptoms: Loss of appetite, nausea, vomiting, headache, irritability, reduced alertness, and intracranial hypertension (historically called pseudotumor cerebri) may be seen. Seizures are uncommon.

Differentiation syndrome during leukemia treatment: Patients receiving oral tretinoin for acute promyelocytic leukemia may develop fever, shortness of breath, lung infiltrates, and fluid around the lungs or heart. Kidney or liver dysfunction may accompany severe cases. This is an urgent treatment-related complication requiring specialist care.

PROCEDURES AND LABORATORY TESTS

Essential Assessment

A detailed history should establish the exact product, dose, route, timing, duration of exposure, and whether any other supplements or medications were taken. An asymptomatic person with an exposure assessed as low risk may not need routine investigations.

Recommended Investigations

Depending on symptoms and exposure history, testing may include a complete blood count; electrolytes, calcium, urea or blood urea nitrogen, and creatinine; liver enzymes; and coagulation studies such as prothrombin time and international normalized ratio.

Bone imaging may be useful in children with suspected prolonged toxicity, including evaluation for osteopenia and periosteal new bone formation. Chest radiography may be indicated when respiratory symptoms occur, particularly during oral tretinoin treatment for leukemia.

A serum vitamin A concentration may contribute to the assessment, but it does not consistently reflect the severity of toxicity and should not be used alone to direct treatment.

TREATMENT

The main treatment for vitamin A excess is to stop the offending exposure and provide supportive care. Clinicians should establish the quantity and timing of every relevant substance and assess for neurologic, hepatic, and metabolic complications.

Differentiation syndrome in a patient receiving oral tretinoin for leukemia requires urgent treatment by the oncology team; management differs from that of routine vitamin A poisoning.

DIRECTING PATIENT CARE

Poison center consultation: Seek toxicology advice after a potentially large ingestion, severe or continuing symptoms, suspected coingestion, or complicating medical conditions or drug interactions.

Referral to a healthcare facility: Emergency evaluation is appropriate for significant symptoms, uncertain or potentially dangerous exposures, suspected deliberate poisoning, or possible self-harm.

Admission considerations: Hospital care may be required for altered consciousness, low blood pressure, cardiac rhythm abnormalities, serious metabolic changes, liver injury, or other significant complications.

DECONTAMINATION

Outside the hospital: Do not induce vomiting. Ipecac syrup is no longer recommended for routine poisoning management.

In the hospital: Gastric lavage is generally not recommended for routine vitamin A or retinoid ingestion. Activated charcoal is not automatically necessary; in selected substantial recent ingestions, a poison specialist may consider whether any gastrointestinal decontamination would offer a benefit that outweighs the risks.

ANTIDOTES

There is no specific antidote for vitamin A or retinoid poisoning.

ADJUNCTIVE TREATMENT

Treatment is directed at complications such as dehydration, electrolyte disturbances, raised intracranial pressure, or liver injury. Although the historical source mentioned naloxone for depressed consciousness, naloxone is not an established reversal agent for vitamin A toxicity and should not be used as a substitute for evaluating other causes of reduced consciousness.

FOLLOW-UP

EXPECTED COURSE AND PROGNOSIS

Symptoms may improve slowly because vitamin A and several related substances are fat-soluble and may remain in tissues. Recovery can require days or longer, depending on the duration and severity of exposure and whether organ injury has occurred.

DISCHARGE CRITERIA AND INSTRUCTIONS

Discharge may be appropriate when significant effects have resolved or stabilized, additional monitoring is unnecessary, and a follow-up plan is established. A mental health assessment is appropriate when intentional self-poisoning is suspected.

Patients should be advised to avoid further excessive vitamin A intake and to review all supplements and prescription retinoids with their healthcare professional.

PITFALLS IN DIAGNOSIS

Unusual dietary exposures should not be overlooked. The liver of certain animals, including polar bears, may contain exceptionally high concentrations of preformed vitamin A and has historically been associated with severe poisoning.

ICD-9-CM CLASSIFICATION

963.5 — Poisoning by vitamins, not elsewhere classified (historical ICD-9-CM code).

Clinical note: This article paraphrases historical material. The original pregnancy categories, dosing thresholds, and decontamination or naloxone recommendations are not substitutes for current medical guidance.



Image description
0 Comments